EC Number |
Substrates |
Organism |
Products |
Reversibility |
---|
3.4.17.11 | (2-chloroethyl)-(2-(methylsulfoyloxyethyl)amino)aminobenzyl-L-glutamic acid + H2O |
a prodrug |
Pseudomonas sp. |
(2-chloroethyl)-(2-(methylsulfoyloxyethyl)amino)aminobenzoic acid + L-glutamate |
- |
? |
3.4.17.11 | (2S,2'S)-2,2'-(pentane-1,5-diylbis[oxy[(11S,11aS)-11-hydroxy-7-methoxy-5-oxo-2,3,11,11a-tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-8,10(5H)-diyl]carbonyloxymethanediylbenzene-4,1-diylcarbamoylimino])dipentanedioic acid + 2 H2O |
- |
Homo sapiens |
(11aS,11a'S)-8,8'-[pentane-1,5-diylbis(oxy)]bis(7-methoxy-1,2,3,11a-tetrahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepin-5-one) + ? |
- |
? |
3.4.17.11 | (2S,2'S)-2,2'-(pentane-1,5-diylbis[oxy[(11S,11aS)-11-hydroxy-7-methoxy-5-oxo-2,3,11,11a-tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-8,10(5H)-diyl]carbonyloxymethanediylbenzene-4,1-diyloxycarbonylimino])dipentanedioic acid + 2 H2O |
- |
Homo sapiens |
3-hydroxybenzyl 4-hydroxybenzyl (11S,11aS,11'S,11a'S)-8,8'-[pentane-1,5-diylbis(oxy)]bis(11-hydroxy-7-methoxy-5-oxo-2,3,11,11a-tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-10(5H)-carboxylate) + 2 N-carboxy-L-glutamate |
- |
? |
3.4.17.11 | (4-[bis(2-bromoethyl)amino]-2,3,5-trifluorobenzoyl)-L-glutamic acid + H2O |
a trifluorinated prodrug |
Pseudomonas sp. |
4-[bis(2-bromoethyl)amino]-2,3,5-trifluorobenzoic acid + L-glutamate |
- |
? |
3.4.17.11 | (4-[bis(2-bromoethyl)amino]-3,5-difluorobenzoyl)-L-glutamic acid + H2O |
a difluorinated prodrug |
Pseudomonas sp. |
4-[bis(2-bromoethyl)amino]-3,5-difluorobenzoic acid + L-glutamate |
- |
? |
3.4.17.11 | (4-[bis(2-bromoethyl)amino]-3,5-difluorobenzoyl)-L-glutamic acid + H2O |
a difluorinated prodrug |
Pseudomonas sp. RS16 |
4-[bis(2-bromoethyl)amino]-3,5-difluorobenzoic acid + L-glutamate |
- |
? |
3.4.17.11 | (4-[bis(2-chloroethyl)amino]-2,3,5-trifluorobenzoyl)-L-glutamic acid + H2O |
a trifluorinated prodrug |
Pseudomonas sp. |
4-[bis(2-chloroethyl)amino]-2,3,5-trifluorobenzoic acid + L-glutamate |
- |
? |
3.4.17.11 | (4-[bis(2-chloroethyl)amino]-3,5-difluorobenzoyl)-L-glutamic acid + H2O |
a difluorinated prodrug |
Pseudomonas sp. |
4-[bis(2-chloroethyl)amino]-3,5-difluorobenzoic acid + L-glutamate |
- |
? |
3.4.17.11 | (4-[bis(2-iodoethyl)amino]-2,3,5-trifluorobenzoyl)-L-glutamic acid + H2O |
a trifluorinated prodrug |
Pseudomonas sp. |
4-[bis(2-iodoethyl)amino]-2,3,5-trifluorobenzoic acid + L-glutamate |
- |
? |
3.4.17.11 | (4-[bis(2-iodoethyl)amino]-3,5-difluorobenzoyl)-L-glutamic acid + H2O |
a difluorinated prodrug |
Pseudomonas sp. |
4-[bis(2-iodoethyl)amino]-3,5-difluorobenzoic acid + L-glutamate |
- |
? |